 ?您的位置：對(duì)照品 > 標(biāo)準(zhǔn)品 > 進(jìn)口標(biāo)準(zhǔn)品 > |
|
|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號(hào)：E521510 |
| 產(chǎn)品名稱(chēng)：Empagliflozin |
| 產(chǎn)品CAS：864070-44-0 |
| 規(guī)格含量：10mg |
| 產(chǎn)品價(jià)格：面議 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細(xì)介紹 |
| 標(biāo)準(zhǔn)品編號(hào): |
E521510 |
| 名稱(chēng): |
Empagliflozin |
| 別名: |
(1S)-1,5-Anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]-D-glucitol; |
| CAS號(hào): |
864070-44-0 |
| 分子式: |
C??H??ClO? |
| 外觀: |
白色至白色固體 |
| 熔點(diǎn): |
151-153°C |
| 分子量: |
450.91 |
| 儲(chǔ)存: |
Hygroscopic, 冰箱保存, under inert atmosphere |
| 溶解度: |
DMSO (Slightly), Methanol (Slightly) |
| 穩(wěn)定性: |
Hygroscopic |
| 種類(lèi): |
Research Tools; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應(yīng)用: |
Empagliflozin is a novel, potent and selective SGLT-2 inhibitor. It improves glycaemic control syndrome in diabetic rats. |
| 參考文獻(xiàn) |
|
|
|
|
|
|
|
|
